Kidney Transplant Patient Data on Th17/Treg Cells and Infection Risk, 2021-2024

A retrospective analysis of 200 patients who underwent kidney transplantation between May 2021 and January 2024. The dataset, authored by Wei Li, compares infection and non-infection groups based on clinical data, Th17/Treg cell ratios, and cytokine levels. It includes results from logistic regression and ROC curve analyses to identify risk factors for post-transplant infection.

Use Cases

• Predicting infection risk after kidney transplantation based on Th17/Treg cell ratios and cytokine levels.
• Identifying independent risk factors for post-transplant infection using multivariate logistic regression analysis.
• Assessing the predictive value of immunological biomarkers via ROC curve analysis, as described in the study.

Strengths

• Contains data from 200 patients, providing a defined cohort size.
• Includes specific immunological measurements such as Th17/Treg cell ratios and levels of IL-17, IL-22, IL-10, and TGF-β.
• Reports a high predictive value with an Area Under the Curve (AUC) of 0.927 for the Th17/Treg ratio.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect temporal bias inherent to the single-center retrospective study design.

Provenance

Source

Wei Li via figshare

Collection Method

Retrospective analysis using flow cytometry and ELISA kits on patient samples.

Time Range

May 2021 to January 2024

Freshness

Last updated 2026-04-30 04:18:37; freshness should be verified.